89941-07-1 Usage
General Description
Ethyl-2-piperazinecarboxylate is a chemical compound with the molecular formula C8H16N2O2. It is a derivative of piperazine and is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. Ethyl-2-piperazinecarboxylate is a white crystalline powder with a mild odor and is soluble in water and most organic solvents. It is primarily used as a building block in the preparation of various pharmaceuticals, including antihistamines, antipsychotics, and antimalarial drugs. It is also used as a corrosion inhibitor and as a component in the synthesis of surfactants and lubricants. Additionally, ethyl-2-piperazinecarboxylate has been studied for its potential use in the treatment of various medical conditions, including cancer and neurodegenerative diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 89941-07-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,9,4 and 1 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 89941-07:
(7*8)+(6*9)+(5*9)+(4*4)+(3*1)+(2*0)+(1*7)=181
181 % 10 = 1
So 89941-07-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H14N2O2/c1-2-11-7(10)6-5-8-3-4-9-6/h6,8-9H,2-5H2,1H3
89941-07-1Relevant articles and documents
COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USES AS IDH1 MUTANTS INHIBITORS FOR TREATING CANCERS
-
, (2013/02/28)
Provided are compounds of formula (I), wherein X, Y, Z, W, V, R2, R3 and m are defined as in the description. Their pharmaceutical compositions and their uses as IDH1 mutants inhibitors for treating cancers are also provided
BICYCLIC PIPERAZINE COMPOUND AND USE THEREOF
-
Page/Page column 58, (2010/11/08)
The present invention provides a compound represented by the formula: wherein R1 is an acyl group, R2 is a hydrocarbon group which may be substituted or the like, R3 is a hydrocarbon group which may be substituted or the like, R4 is a hydrocarbon group which may be substituted or the like, n is from 0 to 4, and X is an oxygen atom, a sulfur atom or the like, or a salt thereof. The invention also provides a compound which has a TGR23 antagonist activity and thus is useful for prevention and treatment of cancer.
Calcium channel inhibitors comprising benzhydril spaced from piperazine
-
, (2008/06/13)
Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
